TY - JOUR AU - S de Guibert, AU - A Jaccard, AU - M Bernard, AU - P Turlure, AU - D Bordessoule, AU - T Lamy, PY - 2006/03/01 Y2 - 2024/03/28 TI - Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma JF - Haematologica JA - haematol VL - 91 IS - 3 SE - Comparative Studies DO - 10.3324/%x UR - https://haematologica.org/article/view/3905 SP - 425-426 AB - We report on a series of 24 patients with newly diagnosed mantle cell lymphoma treated with four to six courses of DHAP-rituximab followed by autologous stem cell transplantation for patients